Rheumatology

SJR Rank #1,845H-index: 212SJR: 1.751Best quartile: Q1APC: US$4,597
Journal website: aims, scope and author guidelines
Publisher

Oxford University Press

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • Pharmacology (medical)Q1
  • RheumatologyQ1

Areas: Medicine

Most published research topics

Rheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchSpondyloarthritis Studies and TreatmentsSystemic Sclerosis and Related DiseasesAutoimmune and Inflammatory Disorders ResearchMusculoskeletal Disorders and RehabilitationVasculitis and related conditionsInflammatory Myopathies and DermatomyositisOtitis Media and Relapsing PolychondritisOsteoarthritis Treatment and Mechanisms

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0550110016502200

Documents per Year

2022202502505007501000

Detailed Information

ISSN

1462-0324, 1462-0332

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

3.70

References per Document

28.17

Coverage

1952-1995, 1998-2026

Scope

Rheumatology strives to support research and discovery by publishing the highest quality original scientific papers with a focus on basic, clinical and translational research. The journal’s subject areas cover a wide range of paediatric and adult rheumatological conditions from an international perspective. It is an official journal of the British Society for Rheumatology, published by Oxford University Press. Rheumatology publishes original articles, reviews, editorials, guidelines, concise reports, meta-analyses, original case reports, clinical vignettes, letters and matters arising from published material. The journal takes pride in serving the global rheumatology community, with a focus on high societal impact in the form of podcasts, videos and extended social media presence, and utilizing metrics such as Altmetric. Keep up to date by following the journal on Twitter @RheumJnl.

Metrics from SCImago Journal Rank 2025. View on SCImago